| Post-procedural results . | ASA . | SM . | P-value . | |
|---|---|---|---|---|
| NYHA | I | 3 (12.5%) | 56 (81.16%) | <0.001 |
| II | 10 (41,67%) | 12 (17.39%) | ||
| III | 11 (45,83%) | 1 (1.45%) | ||
| IV | 0 (0%) | 0 (0%) | ||
| ECG sinus rhythm | 18 (72%) | 58 (78.4%) | 0.004 | |
| Atrial fibrillation | 5 (20%) | 11 (14.9%) | ||
| New pacemaker implantation | 4 (16%) | 2 (2.6%) | 0.013 | |
| Dyspnoea | 12 (75%) | 8 (10.3%) | <0.001 | |
| Angina | 2 (12.5%) | 2 (2.6%) | 0.115 | |
| Syncope | 0 (0%) | 0 (0%) | — | |
| Beta blockers | 24 (96%) | 56 (71.8%) | 0.034 | |
| Calcium channel blockers | 4 (16%) | 3 (3.8%) | 0.054 | |
| Disopyramide | 9 (36%) | 1 (1.3%) | <0.001 | |
| Septal thickness (mm), mean (SD) | 17.94(3.98) | 15.31(3.82) | 0.028 | |
| SAM | 9 (36%) | 17 (21.8%) | 0.482 | |
| Mitral regurgitation ≥3 | 4 (16%) | 4 (5.1%) | 0.323 | |
| Basal LVOT gradients (mmHg), median (p10; p90) | 18 (0; 70) | 0 (0; 17) | <0.001 | |
| Valsalva LVOT gradients (mmHg), median (p10; p90) | 34.5 (8; 90) | 0 (0; 53) | <0.001 | |
| Post-procedural results . | ASA . | SM . | P-value . | |
|---|---|---|---|---|
| NYHA | I | 3 (12.5%) | 56 (81.16%) | <0.001 |
| II | 10 (41,67%) | 12 (17.39%) | ||
| III | 11 (45,83%) | 1 (1.45%) | ||
| IV | 0 (0%) | 0 (0%) | ||
| ECG sinus rhythm | 18 (72%) | 58 (78.4%) | 0.004 | |
| Atrial fibrillation | 5 (20%) | 11 (14.9%) | ||
| New pacemaker implantation | 4 (16%) | 2 (2.6%) | 0.013 | |
| Dyspnoea | 12 (75%) | 8 (10.3%) | <0.001 | |
| Angina | 2 (12.5%) | 2 (2.6%) | 0.115 | |
| Syncope | 0 (0%) | 0 (0%) | — | |
| Beta blockers | 24 (96%) | 56 (71.8%) | 0.034 | |
| Calcium channel blockers | 4 (16%) | 3 (3.8%) | 0.054 | |
| Disopyramide | 9 (36%) | 1 (1.3%) | <0.001 | |
| Septal thickness (mm), mean (SD) | 17.94(3.98) | 15.31(3.82) | 0.028 | |
| SAM | 9 (36%) | 17 (21.8%) | 0.482 | |
| Mitral regurgitation ≥3 | 4 (16%) | 4 (5.1%) | 0.323 | |
| Basal LVOT gradients (mmHg), median (p10; p90) | 18 (0; 70) | 0 (0; 17) | <0.001 | |
| Valsalva LVOT gradients (mmHg), median (p10; p90) | 34.5 (8; 90) | 0 (0; 53) | <0.001 | |
Categorical variables are shown as frequency and percentage. Quantitative variables are shown as mean and standard deviation.
BMI: body mass index; BSA: body surface area; ECG: electrocardiogram; LVOT: left ventricle outflow tract; NYHA: New York Heart Association Class; SAM: systolic anterior motion; SD: standard deviation.
| Post-procedural results . | ASA . | SM . | P-value . | |
|---|---|---|---|---|
| NYHA | I | 3 (12.5%) | 56 (81.16%) | <0.001 |
| II | 10 (41,67%) | 12 (17.39%) | ||
| III | 11 (45,83%) | 1 (1.45%) | ||
| IV | 0 (0%) | 0 (0%) | ||
| ECG sinus rhythm | 18 (72%) | 58 (78.4%) | 0.004 | |
| Atrial fibrillation | 5 (20%) | 11 (14.9%) | ||
| New pacemaker implantation | 4 (16%) | 2 (2.6%) | 0.013 | |
| Dyspnoea | 12 (75%) | 8 (10.3%) | <0.001 | |
| Angina | 2 (12.5%) | 2 (2.6%) | 0.115 | |
| Syncope | 0 (0%) | 0 (0%) | — | |
| Beta blockers | 24 (96%) | 56 (71.8%) | 0.034 | |
| Calcium channel blockers | 4 (16%) | 3 (3.8%) | 0.054 | |
| Disopyramide | 9 (36%) | 1 (1.3%) | <0.001 | |
| Septal thickness (mm), mean (SD) | 17.94(3.98) | 15.31(3.82) | 0.028 | |
| SAM | 9 (36%) | 17 (21.8%) | 0.482 | |
| Mitral regurgitation ≥3 | 4 (16%) | 4 (5.1%) | 0.323 | |
| Basal LVOT gradients (mmHg), median (p10; p90) | 18 (0; 70) | 0 (0; 17) | <0.001 | |
| Valsalva LVOT gradients (mmHg), median (p10; p90) | 34.5 (8; 90) | 0 (0; 53) | <0.001 | |
| Post-procedural results . | ASA . | SM . | P-value . | |
|---|---|---|---|---|
| NYHA | I | 3 (12.5%) | 56 (81.16%) | <0.001 |
| II | 10 (41,67%) | 12 (17.39%) | ||
| III | 11 (45,83%) | 1 (1.45%) | ||
| IV | 0 (0%) | 0 (0%) | ||
| ECG sinus rhythm | 18 (72%) | 58 (78.4%) | 0.004 | |
| Atrial fibrillation | 5 (20%) | 11 (14.9%) | ||
| New pacemaker implantation | 4 (16%) | 2 (2.6%) | 0.013 | |
| Dyspnoea | 12 (75%) | 8 (10.3%) | <0.001 | |
| Angina | 2 (12.5%) | 2 (2.6%) | 0.115 | |
| Syncope | 0 (0%) | 0 (0%) | — | |
| Beta blockers | 24 (96%) | 56 (71.8%) | 0.034 | |
| Calcium channel blockers | 4 (16%) | 3 (3.8%) | 0.054 | |
| Disopyramide | 9 (36%) | 1 (1.3%) | <0.001 | |
| Septal thickness (mm), mean (SD) | 17.94(3.98) | 15.31(3.82) | 0.028 | |
| SAM | 9 (36%) | 17 (21.8%) | 0.482 | |
| Mitral regurgitation ≥3 | 4 (16%) | 4 (5.1%) | 0.323 | |
| Basal LVOT gradients (mmHg), median (p10; p90) | 18 (0; 70) | 0 (0; 17) | <0.001 | |
| Valsalva LVOT gradients (mmHg), median (p10; p90) | 34.5 (8; 90) | 0 (0; 53) | <0.001 | |
Categorical variables are shown as frequency and percentage. Quantitative variables are shown as mean and standard deviation.
BMI: body mass index; BSA: body surface area; ECG: electrocardiogram; LVOT: left ventricle outflow tract; NYHA: New York Heart Association Class; SAM: systolic anterior motion; SD: standard deviation.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
